Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

ClinicalTrials.gov ID: NCT03197766

Public ClinicalTrials.gov record NCT03197766. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The intent and design of this Phase 3 study is to assess BMN 111 as a therapeutic option for the treatment of children with Achondroplasia.

Study identification

NCT ID
NCT03197766
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
BioMarin Pharmaceutical
Industry
Enrollment
121 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
5 Years to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 12, 2016 (Actual)
Primary completion
Oct 30, 2019 (Actual)
Completion
Oct 30, 2019 (Actual)
Last update posted
Mar 2, 2022

2016 – 2019

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
Children's Hospital & Research Center Oakland Oakland California 94609 —
Harbor - UCLA Medical Center Torrance California 90509 —
Alfred I. duPont Hospital for Children Wilmington Delaware 19803 —
Emory University Decatur Georgia 30033 —
Ann and Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 —
Johns Hopkins University Baltimore Maryland 21287 —
University of Missouri Columbia Missouri 65201 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
Baylor College of Medicine Houston Texas 77030 —
Seattle Children's Hospital Seattle Washington 98105 —
Medical College of Wisconsin, Children's Hospital Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03197766, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2022 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03197766 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →